| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |